CA Patent

CA2594345C — Compositions and methods of treating cell proliferation disorders

Assigned to Atnx Spv LLC United States · Expires 2013-11-05 · 13y expired

What this patent protects

The invention relates to compounds and methods for treating cell proliferation disorders. (see above formula)

USPTO Abstract

The invention relates to compounds and methods for treating cell proliferation disorders. (see above formula)

Drugs covered by this patent

Klisyri (TIRBANIBULIN) · Almirall

Patent Metadata

Patent number: CA2594345C
Jurisdiction: CA
Classification: —
Expires: 2013-11-05
Drug substance claim: No
Drug product claim: No
Assignee: Atnx Spv LLC United States
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.